Anticancer therapy using glucuronate modified long-circulating liposomes

Advanced Drug Delivery Reviews

Volumn 40, Issue 1-2, 1999, Pages 63-73

  Oku, Naoto ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Glucuronate; Long circulating liposome; Passive targeting; RES; Reticuloendothelial systems

Indexed keywords

ENCAPSULATION; ONCOLOGY; PHOTODYNAMIC THERAPY;

LIPOSOMES;

CONTROLLED DRUG DELIVERY;

2' C CYANO 2' DEOXY 1 BETA DEXTRO ARABINOPENTOFURANOSYLCYTOSINE; AMPHOPHILE; ANTINEOPLASTIC AGENT; DOXORUBICIN; GLUCURONIC ACID; LIPOPROTEIN; LIPOSOME; MACROGOL; OPSONIN; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER TISSUE; DRUG EFFICACY; DRUG TARGETING; ENCAPSULATION; HUMAN; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; REVIEW; TUMOR VASCULARIZATION;

EID: 0032853891     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(99)00040-X     Document Type: Review

References (40)

1. G. Gregoriadis (Ed.), Liposome Technology, 2nd ed., CRC Press, Boca Raton, 1992.
2. Namba Y., Oku N. Liposomal applications to cancer therapy. J. Bioact. Compat. Polym. 8:1993;158-177.
3. Rolland A. Pharmaceutical Particulate Carriers: Therapeutic Applications. 1993;Marcel Dekker, New York.
4. Lasic D.D. Liposomes: From Physics To Applications. 1993;Elsevier, Amsterdam.
5. Senior J. Fate and behavior of liposomes in vivo: A review of controlling factors. Crit. Rev. Ther. Drug Carrier Syst. 3:1987;123-237.
6. Oku N., Namba Y. Long-circulating liposomes. Crit. Rev. Ther. Drug Carrier Syst. 11:1994;231-270.
7. Woodle M.C., Storm G. Long Circulating Liposomes: Old Drugs, New Therapeutics. 1998;Springer-Verlag, Berlin.
8. Jain R.K. Delivery of molecular medicine to solid tumors. Science. 271:1996;1079-1080.
9. Allen T.M., Chonn A. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett. 223:1987;42-46.
10. Gabizon A., Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA. 85:1988;6949-6953.
11. Yamauchi H., Yano T., Kato T., et al. Effects of sialic acid derivative on long-circulation time and tumor concentration of liposomes. Int. J. Pharm. 113:1995;141-148.
12. Tilcock C., Ahkong Q.F., Fisher D. Polymer-derivatized technetium 99mTc-labeled liposomal blood pool agents for nuclear medicine applications. Biochim. Biophys. Acta. 1148:1993;77-84.
13. Namba Y., Sakakibara T., Masada M., Ito F., Oku N. 1-O-Palmityl-D-glucuronate endows liposomes with long half-life in vivo. Chem. Lett. 1989:1989;2145-2148.
14. Oku N., Namba Y., Okada S. Tumor accumulation of novel RES-avoiding liposomes. Biochim. Biophys. Acta. 1126:1992;255-260.
15. Blume G., Cevc G. Liposomes for the sustained drug release in vivo. Biochim. Biophys. Acta. 1029:1990;91-97.
16. Klibanov A.L., Maruyama K., Torchilin V.P., Huang L. Amphiphathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268:1990;235-237.
17. Allen T.M., Hansen C., Martin F., Redeman C., Yau-Yong A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta. 1066:1991;29-36.
18. Delgado Senior J., Fisher C., Tilcock D. C., Gregoriadis, G., Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim. Biophys. Acta. 1062:1991;77-82.
19. Oku N. Basic study and application of functional liposomes. Cell. Mol. Biol. Lett. 1:1996;417-427.
20. Namba Y., Sakakibara T., Masada M., Ito F., Oku N. Glucuronate-modified liposomes with prolonged circulation time. Chem. Pharm. Bull. 38:1990;1663-1666.
21. Namba Y., Oku N., Ito F., Sakakibara T., Okada S. Liposomal modification with uronate, which endows liposomes with long-circulation in vivo, reduces the uptake of liposomes by J774 cells in vitro. Life Sci. 50:1992;1773-1779.
22. Oku N., Tokudome Y., Namba Y., et al. Effect of serum protein binding on real-time trafficking of liposomes with different charges analyzed by positron emission tomography. Biochim. Biophys. Acta. 1280:1996;149-154.
23. Chonn A., Semple S.C., Cullis P.R. Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. J. Biol. Chem. 267:1992;18759-18765.
24. Chonn A., Semple S.C., Cullis P.R. Separation of large unilamellar liposomes from blood components by a spin column procedure: towards identifying plasma proteins which mediate liposome clearance in vivo. Biochim. Biophys. Acta. 1070:1991;215-222.
25. Oku N., Tokudome Y., Tsukada H., Kosugi T., Namba Y., Okada S. In vivo trafficking of long-circulating liposomes in tumour-bearing mice determined by positron emission tomography. Biopharm. Drug Dispos. 17:1996;435-441.
26. Oku N., Tokudome Y. Tsukada. H., Okada, S., Real-time analysis of liposomal trafficking in tumor-bearing mice by use of positron emission tomography. Biochim. Biophys. Acta. 1238:1995;86-90.
27. Oku N., Namba Y., Takeda A., Okada S. Tumor imaging with technetium-99m-DTPA encapsulated in RES-avoiding liposomes. Nucl. Med. Biol. 20:1993;407-412.
28. Oku N., Doi K., Namba Y., Okada S. Therapeutic effect of adriamycin encapsulated in long-circulating liposomes on Meth-A-sarcoma-bearing mice. Int. J. Cancer. 58:1994;415-419.
29. Northfelt D.W. Pegylated-liposomeal doxorubicin (Doxil) in the treatment of AIDS-related Kaposi's sarcoma. Woodle M.C., Storm G. Long Circulating Liposomes: Old Drugs, New Therapeutics. 1998;127-145 Springer-Verlag, Berlin.
30. Mukwaya G., Forssen E.A., Schmidt P., Ross M. DaunoXome (liposomal daunorubicin) for first-line treatment of advanced, HIV-related Kaposi's sarcoma. Woodle M.C., Storm G. Long Circulating Liposomes: Old Drugs, New Therapeutics. 1998;147-163 Springer-Verlag, Berlin.
31. Tokudome Y., Oku N., Namba Y., Okada S. Antitumor activity of vincristine encapsulated in glucuronide-modified long-circulating liposomes in mice bearing Meth A sarcoma. Biochim. Biophys. Acta. 1279:1996;70-74.
32. Vaage J., Donovan D., Mayhew E., Uster P., Woodle M. Therapy of mouse mammary carcinomas with vincristine and doxorubicin encapsulated in sterically stabilized liposomes. Int. J. Cancer. 54:1993;959-964.
33. Matsuda A., Nakajima Y., Azuma A., Tanaka M., Sasaki T. Nucleosides and nucleotides. 100. 2′-C-cyano-2′-deoxy-1-b-D-arabinofuranosyl-cytosine (CNDAC): Design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside. J. Med. Chem. 34:1991;2917-2919.
34. Shuto S., Awano H., Shimazaki N., Hanaoka K., Matsuda A. Bioorg. Med. Chem. Lett. 6:1996;1021-1024.
35. Asai T., Kurohane K., Shuto S., et al. Antitumor activity of 5′-O-dipalmitoylphosphatidyl 2′-C-cyano-2′-deoxy-1-b-D-arabiono-pentofuranosylcytosine is enhanced by long-circulating liposomalization. Biol. Pharm. Bull. 21:1998;766-771.
36. Doi K., Oku N., Toyota T., Shuto S., Sakai A., Itoh H. Okada, S. (1994) Therapeutic effect of reticuloendothelial system (RES)-avoiding liposomes containing a phospholipid analogue of 5-fluorouracil, dipalmitoylphosphatidylfluorouridine, in Meth A sarcoma-bearing mice. Biol. Pharm. Bull. 17:(1994):1994;1414-1416.
37. Richter A.M., Yip S., Waterfield E., Logan P.M., Slonecker C.E., Levy J.G. Mouse skin photosensitization with benzoporphyrin derivatives and Photofrin: macroscopic and microscopic evaluation. Photochem. Photobiol. 53:1991;281-286.
38. Richter A.M., Cerruti-Sola S., Sternberg E.D., Dolphin D., Levy J.G. Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice. J. Photochem. Photobiol. 5:(1990):1990;231-244.
39. Richter A.M., Waterfield E., Jain A.K., Canaan A.J., Allison B.A., Levy J.G. Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model. Photochem. Photobiol. 57:1993;1000-1006.
40. Oku N., Saito N., Namba Y., Tsukada H., Dolphin D., Okada S. Application of long-circulating liposomes to cancer photodynamic therapy. Biol. Pharm. Bull. 20:1997;670-673.